Metabolic Syndrome Among Testicular Cancer Survivors: Long‐Term Follow‐Up of the Veterans Affairs Health System
Cancer Medicine · 2025
DOI: 10.1002/cam4.70858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Dhruv Puri und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Testicular Neoplasms, Cancer Survivors, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The 5‐year survival rate for patients with testicular germ cell tumors (TC) is excellent. However, these survivors are at an increased risk for metabolic syndrome (MetS), a significant source of morbidity and precursor to cardiovascular disease. This study investigates the incidence of MetS in TC survivors compared to matched controls.
Methods
A retrospective analysis was conducted using the Veterans Affairs national database. The incidence of MetS was compared between 2021 TC survivors and 7595 matched controls. MetS was identified via diagnostic codes and medication use, requiring at least three of five criteria: insulin resistance, dyslipidemia, central obesity, and hypertension. Statistical analysis included chi‐squared and t ‐tests for demographic comparisons, and Cox regression for outcome associations.
Results
TC survivors exhibited a greater prevalence of MetS components than controls, specifically hyperglycemia (28.4%), low HDL levels (59.8%), hypertriglyceridemia (8.0%), and abdominal obesity (27.3%), except for hypertension. Over 5 and 10 years, the cumulative incidence of MetS in TC survivors was 17.0% and 27.8%, compared to 1.9% and 2.8% in controls. Multivariate regression showed an increased incidence of MetS in TC survivors (HR = 19.02, 95% confidence interval [CI]: 16.31–22.19, p < 0.001). Chemotherapy (HR = 1.28, 95% CI: 1.04–1.57, p = 0.017) and increasing age (HR = 1.04, 95% CI: 1.04–1.06, p < 0.001) were associated with a higher risk.
Conclusions
TC survivors have a substantial risk of MetS with a higher occurrence of most MetS components, barring hypertension. Comprehensive metabolic health monitoring is crucial in TC survivorship care. Integrating vigilant screening and preventive strategies can mitigate MetS development in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA.
- Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California, USA.
- VA Hospital San Diego, San Diego, California, USA.
- Department of Urology, UTSW School of Medicine, Dallas, Texas, USA.
- Division of Hematology and Oncology, Department of Medicine, UC San Diego School of Medicine, La Jolla, California, USA.
- Department of Urology, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
ORCID-Profile: Dhruv Puri, Tyler Nelson, Juan Javier-Desloges, Amirali Salmasi
Zitieren
APA
Puri, D., Riviere, P., Meagher, M., Morgan, K., Nelson, T., Yuen, K., Pandit, K., Yodkhunnatham, N., Taylor, J., Herchenhorn, D., Stewart, T., Javier-Desloges, J., Salmasi, A., McKay, R. R., Kern, S. Q., Hofflich, H., Millard, F., Rose, B., & Bagrodia, A. (2025). Metabolic Syndrome Among Testicular Cancer Survivors: Long‐Term Follow‐Up of the Veterans Affairs Health System. Cancer Medicine. https://doi.org/10.1002/cam4.70858
Vancouver
Puri D, Riviere P, Meagher M, Morgan K, Nelson T, Yuen K, et al. Metabolic Syndrome Among Testicular Cancer Survivors: Long‐Term Follow‐Up of the Veterans Affairs Health System. Cancer Medicine. 2025. doi:10.1002/cam4.70858
BibTeX
@article{Puri2025,
author = {Puri, Dhruv and Riviere, Paul and Meagher, Margaret and Morgan, Kylie and Nelson, Tyler and Yuen, Kit and Pandit, Kshitij and Yodkhunnatham, Nuphat and Taylor, Jacob and Herchenhorn, Daniel and Stewart, Tyler and Javier-Desloges, Juan and Salmasi, Amirali and McKay, Rana R and Kern, Sean Q and Hofflich, Heather and Millard, Frederick and Rose, Brent and Bagrodia, Aditya},
title = {Metabolic Syndrome Among Testicular Cancer Survivors: Long‐Term Follow‐Up of the Veterans Affairs Health System},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70858}
}
EUVIMED